21.87 USD
↗ 0.43 (2.01%)AT CLOSE (03:59 PM EDT)
Braveheart Bio, Inc. Common Stock
BRVENASDAQ • USD
21.99
↗ 0.12 (0.55%)
POST MARKET (AS OF 07:30 PM EDT)
Post Market
AS OF 07:30 PM EDT
21.99
↗ 0.12 (0.55%)
Market: CLOSED
BRVE is currently priced at $21.92. The technical outlook is "Buy" based on moving average alignment, RSI, and MACD signals. Key drivers include a bearish Death Cross on the long-term moving averages.
Technical & fundamental data as of Oct 26, 2026.
Open?$21.37
High?$21.98
Low?$21.10
Prev. Close?$21.44
Volume?101.2K
Avg. Volume?N/A
VWAP?$21.73
Bid / Ask
Bid?$20.88 × 100
Ask?$24.88 × 800
Spread?$4.00
Midpoint?$22.88
Valuation & Ratios
Market Cap?1.9B
Shares Out?N/A
Float?56.2M
Float %?62.4%
P/E Ratio?N/A
P/B Ratio?N/A
EPS?N/A
Dividend?N/A
Ex-Dividend?N/A
News
Profile
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
Employees
N/A
Market Cap
1.9B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2026-08-06
Address
ONE LETTERMAN DR.
SAN FRANCISCO, CA 94129
Phone: (415) 707-6312
SAN FRANCISCO, CA 94129
Phone: (415) 707-6312
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?8.73%Elevated
Short Interest?4.9M
Days to Cover?11.8
Free Float56.2M
Avg Daily Volume417.1K
Settlement Date2026-10-15